|
| TUSY08 |
Public Health-Oriented Management of Intellectual Property Rights: Overcoming Barriers to Access for Second Line ARV Drugs |
| |
Symposia Session
|
| Venue: |
Session Room 6 |
| Time: |
24.07.2012, 16:30 - 18:00 |
|
Chair:
|
Denis Broun, Switzerland
|
| |
| |
| Reducing costs of treatment regimens is one of the five pillars of the Treatment 2.0 platform launched by UNAIDS and the World Health Organization in 2010. Intellectual Property Rights (IPR) still remain a critical barrier to implementing innovative approaches to achieve more affordable prices. Even following the Doha Declaration adoption in 2001, developing countries face difficulties to making full use of Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities. Bilateral trade agreements are another area of concern and the patent status for newer antiretroviral medications in manufacturer countries may hamper generic competition. The objective of this symposia session is to review lessons learned since the Doha Declaration, and identify opportunities for the future to provide options for maintaining and expanding the gains that the global community has made in equitable and universal access to HIV treatment. |
|
|
16:30
| Introduction
| 16:37
TUSY0801
Webcast | ARV needs in the framework of Treatment 2.0
S. Zaidi, Thailand
| 16:49
TUSY0802
Webcast | Implementing TRIPS flexibilities: experiences from the ground
M. Vieira, Brazil
| 17:01
TUSY0803 | Recent IP developments in India and their impact on access to essential medicines in the global south
K. Bhardwaj, India
| 17:13
TUSY0804
Webcast | Alternative models and strategies for IPR management
B. Baker, United States
| 17:25
TUSY0805
Webcast | Innovative initiatives to stimulate research and development within the health sector
T. Amin, United States
| 17:37
| Questions and answers
|
|
|